Increasing the Efficacy of Gold Nanorod Uptake in Stem Cell-Derived Therapeutic Cells: Implications for Stem Cell Labeling and Optical Coherence Tomography Imaging
- PMID: 39781112
- PMCID: PMC11706712
- DOI: 10.1021/acsanm.2c00958
Increasing the Efficacy of Gold Nanorod Uptake in Stem Cell-Derived Therapeutic Cells: Implications for Stem Cell Labeling and Optical Coherence Tomography Imaging
Abstract
The advancement of safe nanomaterials for use as optical coherence tomography (OCT) imaging and stem cell-labeling agents to longitudinally visually track therapeutic derived retinal stem cells to study their migration, survival rate, and efficacy is challenged by instability, intracellular aggregation, low uptake, and cytotoxicity. Here, we describe a series of hybrid lipid-coated gold nanorods (AuNRs) that could solve these issues. These nanomaterials were made via a layer-by-layer assembly approach, and their stability in biological media, mechanism, efficiency of uptake, and toxicity were compared with a commercially available set of AuNRs with a 5 nm mesoporous silica (mSiO2)-polymer coating. These nanomaterials can serve as stem cell labeling and OCT imaging agents because they absorb in the near-infrared (NIR) region away from biological tissues. Although both subtypes of AuNRs were taken up by retinal pigment epithelial, neural progenitor, and baby hamster kidney cells, slightly negatively charged hybrid lipid-coated AuNRs had minimal aggregation in biological media and within the cytoplasm of cells (~3000 AuNRs/cell) as well as minimal impact on cell health. Hybrid lipid-coated AuNRs modified with cell-penetrating peptides had the least toxicological impact, with >92% cell viability. In contrast, the more "sticky" AuNRs with a 5 nm mSiO2-polymer coating showed significant aggregation in biological media and within the cytoplasm with lower-than-expected uptake of AuNRs (~5400 of AuNRs/cell) given their highly positive surface charge (35+ mV). Collectively, we have demonstrated that hybrid lipid-coated AuNRs, which absorb in the NIR-II region away from biological tissues, with tuned surface chemistry can label therapeutic derived stem cells with minimal aggregation and impact on cell health as well as enhance uptake for OCT imaging applications.
Keywords: cell uptake studies; cell-penetrating peptides; lipid-coated gold nanorods; optical coherence tomography imaging; stem cells; toxicity.
Conflict of interest statement
The authors declare no competing financial interest.
Figures











Similar articles
-
Gold nanoclusters modified mesoporous silica coated gold nanorods: Enhanced photothermal properties and fluorescence imaging.J Photochem Photobiol B. 2021 Feb;215:112111. doi: 10.1016/j.jphotobiol.2020.112111. Epub 2020 Dec 26. J Photochem Photobiol B. 2021. PMID: 33373860
-
The influence of polyethylene glycol passivation on the surface plasmon resonance induced photothermal properties of gold nanorods.Nanoscale. 2018 Jul 19;10(28):13684-13693. doi: 10.1039/c8nr03026j. Nanoscale. 2018. PMID: 29989133
-
High-throughput in-focus differential interference contrast imaging of three-dimensional orientations of single gold nanorods coated with a mesoporous silica shell.RSC Adv. 2020 Aug 12;10(50):29868-29872. doi: 10.1039/d0ra04704j. eCollection 2020 Aug 10. RSC Adv. 2020. PMID: 35518257 Free PMC article.
-
Surface Modification of Gold Nanorods: Multifunctional Strategies and Application Prospects.Chemistry. 2024 Dec 13;30(70):e202400851. doi: 10.1002/chem.202400851. Epub 2024 Nov 7. Chemistry. 2024. PMID: 39352147 Review.
-
A Review on Cancer Therapy Based on the Photothermal Effect of Gold Nanorod.Curr Pharm Des. 2019;25(46):4836-4847. doi: 10.2174/1381612825666191216150052. Curr Pharm Des. 2019. PMID: 31840600 Review.
References
-
- Stone EM A very effective treatment for neovascular macular degeneration. N. Engl. J. Med 2006, 355, 1493–1495. - PubMed
-
- Scarfe L; Brillant N; Kumar JD; Ali N; Alrumayh A; Amali M; Barbellion S; Jones V; Niemeijer M; Potdevin S; Roussignol G; Vaganov A; Barbaric I; Barrow M; Burton NC; Connell J; Dazzi F; Edsbagge J; French NS; Holder J; Hutchinson C; Jones DR; Kalber T; Lovatt C; Lythgoe MF; Patel S; Patrick PS; Piner J; Reinhardt J; Ricci E; Sidaway J; Stacey GN; Starkey Lewis PJ; Sullivan G; Taylor A; Wilm B; Poptani H; Murray P; Goldring CEP; Park BK Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies. npj Regener. Med 2017, 2, 28. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous